You Feel Inflamed, Yet Doctors Find Nothing. Here's the Biological Reason.

TNF-alpha is one of your body’s primary inflammatory messengers. When your immune system detects a threat, TNF-alpha surges to coordinate the inflammatory response, triggering fever, pain, and increased vascular permeability so immune cells can reach the affected area. In the short term, this is protective. Once the threat is cleared, TNF-alpha levels should drop back down.

The TNF -308G>A variant, carried by approximately 30% of people with European ancestry, increases baseline TNF-alpha production by up to 25-50%. Your immune system is essentially set to a higher default inflammatory volume. You’re not overreacting to specific threats; you’re producing more of this signaling molecule all the time, which amplifies every inflammatory signal your body processes.

You experience this as joints that feel stiff and achy even on rest days, skin that flares more easily and takes longer to calm down, and a sense of general achiness that seems disproportionate to your activity level. Recovery from minor injuries or infections also takes longer because your baseline inflammatory state is already elevated.

IL-6 is an inflammatory cytokine that amplifies and extends inflammatory responses. It’s produced by immune cells and also by adipose tissue and muscle in response to TNF-alpha signaling. Once IL-6 is released, it triggers further inflammatory cascades, including the production of CRP (C-reactive protein) in the liver. IL-6 also crosses the blood-brain barrier, where it drives neuroinflammation, affecting mood, cognition, and sleep quality.

The IL6 -174G>C variant is carried by roughly 40% of the population. People with the C allele produce higher baseline IL-6 levels, which means inflammatory signals get amplified more aggressively. What starts as a minor immune signal cascades further and persists longer in your system.

You experience this as inflammation that seems to build rather than resolve, brain fog that intensifies when your body is inflamed, mood changes that correlate with flares, and sleep disruption even when you’re not consciously stressed. Your skin may be particularly reactive because skin is highly sensitive to IL-6 signaling.

SOD2 is an antioxidant enzyme that lives inside your mitochondria and neutralizes superoxide radicals, which are highly reactive molecules produced during energy metabolism. When superoxide accumulates, it triggers oxidative stress, which activates inflammatory pathways as your body tries to signal for repair. SOD2 is your first line of defense against this cascade.

The SOD2 Val16Ala variant is carried by approximately 40% of the population in homozygous form. People with the Ala16 homozygous genotype produce less efficient SOD2 protein, which means superoxide accumulates more readily in your mitochondria, triggering chronic low-level oxidative stress that keeps inflammatory pathways active. Your cells are constantly signaling that something needs to be repaired, even when nothing acute is wrong.

You experience this as fatigue that seems disconnected from activity level, muscle soreness that persists longer than expected, skin that shows oxidative damage (dullness, accelerated aging), and inflammation that worsens with intense exercise rather than improving. Heat exposure and stressful periods amplify symptoms because they increase mitochondrial reactive molecule production.

MTHFR catalyzes a critical step in the methylation cycle, a metabolic pathway that produces the methyl groups your cells use for DNA repair, immune regulation, and detoxification. When MTHFR works efficiently, your cells have a steady supply of methyl donors. When MTHFR is impaired, methylation capacity drops, and several consequences cascade: reduced immune tolerance (your immune system becomes more reactive), impaired detoxification (inflammatory molecules accumulate), and reduced DNA repair (cells stay inflamed longer).

The MTHFR C677T variant, carried by approximately 35-45% of the population, reduces enzyme efficiency by 30-40%. Homozygous carriers experience more significant reductions. Less methylation capacity means your cells have fewer resources to suppress inflammatory gene expression and repair inflammatory damage.

You experience this as inflammation that doesn’t respond well to antioxidants alone, fatigue that improves with certain B vitamins but not others, and symptoms that worsen when you’re stressed (stress depletes methylation capacity further). Your immune system may also struggle to distinguish self from non-self, making you more reactive to minor triggers.

GSTM1 is a detoxification enzyme that binds glutathione to toxins, making them water-soluble so they can be excreted. It’s particularly important for clearing environmental toxins, certain medications, and products of oxidative stress. When GSTM1 works, your cells can clear inflammatory molecular debris. When it doesn’t, that debris accumulates, triggering further immune activation.

The GSTM1 null genotype, present in roughly 50% of the population, means you have zero functional copies of this gene. You’re missing an entire detoxification pathway, which means your liver works harder to clear everything else, and inflammatory molecules that GSTM1 would normally handle accumulate in your tissues instead.

You experience this as inflammation that spikes after chemical exposure (cleaning products, fragrances, pesticides), slower recovery from infections, and symptoms that worsen in inflammatory environments. Your body may struggle to clear even normal metabolic waste, so inflammation builds over time rather than resolving cleanly.

CRP is an acute phase protein produced by your liver in response to IL-6. It circulates in your blood and activates complement, a cascade of proteins that amplifies inflammatory response. CRP levels are traditionally measured to assess inflammation, but CRP itself is also a driver of further inflammation. Higher baseline CRP production means your inflammatory responses are amplified at every step.

The CRP +1444C>T variant, carried by approximately 30% of the population, influences your baseline CRP levels and determines how aggressively your liver responds to inflammatory signals. People with the T allele tend to produce higher CRP at baseline and mount larger CRP spikes in response to minor immune stimuli.

You experience this as bloodwork that shows elevated CRP (sometimes described as “mildly elevated” or “borderline”), inflammation that persists after acute stressors have passed, and symptoms that correlate closely with CRP spikes. Your body may struggle to transition out of inflammatory mode once activated, so recovery is slower and flares last longer.